4
42
Growth Score
-8 pts
Heat Score
-5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
296134
Biosynth's mission is to supply critical raw materials and services to the pharmaceutical and diagnostic industries
Acquired by 
Kohlberg Kravis Roberts & Co.
- Past Role: General Electric, Head of Corporate Development
- Kieran Murphy: ChairmanPast Role: GE Healthcare, President & CEO
About the Company
Biosynth's vision is to consolidate the highly fragmented and complex supply chain. Biosynth increases productivity of the pharmaceutical and diagnostics industries by improving availability and reducing time-to-market of new therapies and diagnostics assays. Biosynth is a Custom Synthesis and Manufacturing Services Company with global
research, manufacturing and distribution facilities. Our core areas are across complex chemicals, peptides and key biological materials. WE also have a research product catalog of over 1M products to support R&D.
